Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in developing treatments for solid tumors and hematological malignancies due to its ability to modulate signaling pathways. Also employed in the design of selective inhibitors for inflammatory and neurodegenerative diseases. Its structure supports high binding affinity to ATP-binding sites in enzymes, making it valuable in structure-activity relationship (SAR) studies. Commonly utilized in early-stage drug discovery for optimizing potency and selectivity.